Elsevier

Pathology

Volume 28, Issue 3, 1996, Pages 277-280
Pathology

Parvovirus B19 In HIV infection: A treatable cause of anemia

https://doi.org/10.1080/00313029600169154Get rights and content

Summary

We describe the case of an adult male patient with AIDS who presented with severe anemia and on investigation was found to have red cell aplasia due to parvovirus B19 infection. Bone marrow examination revealed absence of erythroid development and rare giant pronormoblasts. Repeated serological examinations revealed a low level of parvovirus IgM but no IgG. Viremia was demonstrated by electron microscopy and by the polymerase chain reaction (PCR).

The patient’s initial hemoglobin was 45 g/l and over a four month period he required twenty units of blood. He was treated with intravenous immunoglobulin (Intragam, CSL) at a dose of 400 mg/kg/day for five days. This led to an increase in his hemoglobin to 135 g/l. Parvovirus remained detectable by PCR but not by electron microscopy.

Six months later the patient relapsed (Hb 65 g/l). Again he was transfused and treated with intravenous immunoglobulin for five days. His hemoglobin rose to 153 g/l and remained stable. He subsequently received maintenance treatment with 30 g of intagram once a month.

We recommend that parvovirus be considered in any HIV infected patient with recurrent anemia.

References (20)

There are more references available in the full text version of this article.

Cited by (24)

  • Parvovirus B19: a Clinical and Diagnostic Review

    2022, Clinical Microbiology Newsletter
    Citation Excerpt :

    Clinical manifestations of B19V infections in these patients include fatigue and pallor, often in the absence of rash and arthralgia [46]. Anemia often promptly remits after immunoglobulin therapy or cessation of chemotherapy [54,55]. People with decreased red cell production, increased destruction, or loss are at risk of developing transient aplastic crisis following B19V infection (Table 1).

  • Viruses and Kidney Disease: Beyond HIV

    2008, Seminars in Nephrology
    Citation Excerpt :

    Among immunocompromised individuals, including those receiving immunosuppressive therapy and those infected with HIV, B19 infection can become persistent as a result of the inability to mount an effective humoral and/or cellular response. Pure red cell aplasia is the most common presentation of persistent parvoviral infection in HIV-infected patients.87-90 Whether parvovirus infection has any pathogenic role in renal or urologic disease in HIV-infected patients is unknown.

View all citing articles on Scopus
View full text